University of Florida College of Medicine Jacksonville Program

The University of Florida College of Medicine Jacksonville offers a comprehensive three-year ACGME-accredited fellowship in hematology and medical oncology. This program is designed to equip fellows with the necessary skills to excel in the evaluation and management of hematologic and oncologic diseases.

Program Structure

The fellowship program consists of three clinical fellowship years: the first year focuses on core competencies; the second year emphasizes advanced clinical training; and the third year allows for specialized training, including research and academic opportunities.

Clinical Rotations

Fellows participate in diverse clinical activities, gaining exposure to various oncology and hematology practices. Rotations occur at multiple clinical sites, allowing fellows to collaborate with faculty and healthcare professionals in a multifaceted healthcare environment. These settings is essential for fostering comprehensive cancer care practices.

Curriculum Overview

The curriculum is structured across three years:

• First Year (FELL-1): Introduction to hematology and oncology, coupled with core clinical training.
• Second Year (FELL-2): Advanced clinical training with special attention to outpatient and inpatient management.
• Third Year (FELL-3): Focus on research and the opportunity to fine-tune clinical expertise.

Research Opportunities

The program encourages active participation in clinical research. Faculty members guide fellows in developing and conducting research studies, which are often part of a wider initiative involving participation in prospective clinical trials targeting various cancers and blood disorders. Research coordinators facilitate the enrollment and management of clinical trials.

Application Process and Requirements

To qualify for the fellowship, applicants must have completed an ACGME-accredited internal medicine residency and be eligible for the American Board of Internal Medicine certification. Other essential requirements include a written recommendation from the residency program director and participation in a personal interview conducted virtually. The program accepts three fellows annually.

Competitive Nature

The fellowship is competitive and seeks highly motivated individuals wishing to specialize in hematology and medical oncology. Aspects such as a strong academic background and compelling personal statements are critical. The program considers both MD and DO candidates, as well as international medical graduates (IMGs), provided they meet the established qualifications.

Visa Sponsorship

The University of Florida College of Medicine Jacksonville offers support for visa sponsorship, particularly for J-1 and H-1B visas for international fellows, facilitating their participation in the training program. This visa support is critical for attracting skilled IMGs who are looking for quality fellowship opportunities in the United States.

Benefits and Resources

Fellows benefit from various offerings, such as health insurance, professional liability coverage, and an array of stipends. Additionally, the program promotes a supportive environment through resources like a counseling service, allowing fellows to manage wellness and work-life balance effectively.

The program also encourages participation in medical education resources and peer support initiatives, positioning fellows to enhance their educational experience dynamically.

Key Training Sites

Fellows can expect to rotate through UF Health Jacksonville and other affiliated locations, providing a comprehensive and diverse training experience across various specialties within hematology and oncology. This multi-site approach is integral for fellows seeking in-depth clinical exposure.

Unique Aspects of the Program

The fellowship prioritizes a comprehensive approach to hematology and oncology, emphasizing patient care, education, and research. Notable collaborations with institutions, such as the UF Health Proton Therapy Institute, enhance the breadth of clinical experience for fellows, enabling them to approach cancer treatment from multiple modalities.